SEC Form D · filed February 4, 2022
Dewpoint Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (35)
Ameet A. Nathwani, M.D · Boston, MAExec · DirectorRichard A. Young, Ph.D · Boston, MADirectorIsaac A. Klein, M.D., Ph.D · Boston, MAExecLori A. Escobedo · Boston, MAExecMark A. Murcko, Ph.D · Boston, MADirectorAnthony A. Hyman, Ph.D · Boston, MADirectorOlivier H. Brandicourt, M.D · Boston, MADirectorSrinivas H. Akkaraju, M.D., Ph.D · Boston, MADirectorRegina A. Barzilay, Ph.D · Boston, MADirectorAmir H. Nashat · Boston, MADirectorPaul Coombs · Waterbury, VTDirectorBraxten Gorrill · Waterbury, VTExec · DirectorAmerican Revitalization Company, LLC · Nashville, TNExecJay Bellows · Waterbury, VTDirectorMatthew D. Still · Nashville, TNDirectorLindsay Gorrill · Waterbury, VTDirectorGregg Noble · Waterbury, VTExecAdam Silver · San Francisco, CADirectorNeil Devani · San Francisco, CADirectorGiuseppe H. Ciaramella, Ph.D · Boston, MADirectorJoel D. Sendek · Boston, MAExecJuergen A. Eckhardt, M.D · Boston, MADirectorMatias Gandulfo · Montara, CADirectorShawn B. Grosser · Bethesda, MDDirectorPablo Villalba · Wilmington, DEDirectorAndrew Somers · Princeton, NJExecMelanie B. Domres · Bethesda, MDExec · DirectorMatthew B. Campbell · Toronto, Ontario, CanadaDirectorAkash Patel · Princeton, NJDirectorFirat Yerlikaya · Wilmington, DEExecBarry R. Mandel · Milwaukee, WIDirectorGiuseppe H. Ciaramella, Ph.D · Boston, MADirectorJoel D. Sendek · Boston, MAExecJuergen A. Eckhardt, M.D · Boston, MADirectorAmir H. Nashat · Cambridge, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗